With two marquee scientific conferences, the Society for Gynecologic Oncology (SGO) and the American Association for Cancer Research (AACR), occurring back-to-back, the past few weeks have seen an explosion in … Continued
This month, we celebrate Liz Tilberis, beloved former president of OCRF and editor-in-chief of Harper's Bazaar.
(April 15, 2014) Prolonged (>35 days), infrequent, or anovulatory menstrual cycles was associated with as much as a two-fold increase in ovarian cancer and more than a three-fold increase in … Continued
(April 8, 2014) A team of researchers have found that vigorous physical activity prior to ovarian cancer diagnosis was associated with a lower risk of ovarian cancer mortality. The findings … Continued
Designer Charity Sale expands to the West Coast in celebration of OCRF’S 20th Anniversary; Offers Day-Long Luxury Experiences for the Whole Family Los Angeles, CA (April 7, 2014) – Rachel … Continued
(April 7, 2014) A group of OCRF-funded researchers at Baylor College of Medicine have found a “fusion gene” that is present in 20% of high grade serous ovarian cancer patients. … Continued
Each spring, Congress takes up the task of allocating money to federal programs. And each spring, the Ovarian Cancer National Alliance works to ensure that ovarian cancer research funding remains … Continued
Last week marked the 20th year anniversary of the discovery of the BRCA1 gene by Mary-Claire King, Ph.D., an American geneticist. Dr. King, who was interviewed last week by NPR, … Continued
Compiled by Robin Cohen, President-Elect, Ovarian Cancer National Alliance As in years past, a wealth of clinical research into ovarian cancer was presented at the 2014 Society for Gynecologic Oncology … Continued
(April 1, 2014) Ovarian Cancer Research Fund is now accepting Letters of Intent for its three research grant programs. Letters of Intent must be submitted by May 6, 2014 at … Continued
A rare type of ovarian cancer called small cell carcinoma of the ovary, hypercalcemic type (or SCCOHT) can affect women and girls as young as 14 months old. This week, … Continued
Last week, the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP – the equivalent to the FDA in the United States, recommended approval for vynfinit in … Continued
Get email updates about research news, action alerts, and ways to join the fight.
